Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic.

Frankell AM, Jammula S, Li X, Contino G, Killcoyne S, Abbas S, Perner J, Bower L, Devonshire G, Ococks E, Grehan N, Mok J, O'Donovan M, MacRae S, Eldridge MD, Tavaré S; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Fitzgerald RC.

Nat Genet. 2019 Mar;51(3):506-516. doi: 10.1038/s41588-018-0331-5. Epub 2019 Feb 4.

2.

The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma.

Contino G, Vaughan TL, Whiteman D, Fitzgerald RC.

Gastroenterology. 2017 Sep;153(3):657-673.e1. doi: 10.1053/j.gastro.2017.07.007. Epub 2017 Jul 14. Review.

3.

Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors.

Roy S, Weinstock JL, Ishino AS, Benites JF, Pop SR, Perez CD, Gumbs EA, Rosenbaum JA, Roccato MK, Shah H, Contino G, Hunter K.

J Clin Med Res. 2017 Jul;9(7):638-649. doi: 10.14740/jocmr3066w. Epub 2017 May 22.

4.

The Medicalization of Health and Shared Responsibility.

Contino G.

New Bioeth. 2016 Apr;22(1):45-55. doi: 10.1080/20502877.2016.1151253.

PMID:
28219279
5.

Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Secrier M, Li X, de Silva N, Eldridge MD, Contino G, Bornschein J, MacRae S, Grehan N, O'Donovan M, Miremadi A, Yang TP, Bower L, Chettouh H, Crawte J, Galeano-Dalmau N, Grabowska A, Saunders J, Underwood T, Waddell N, Barbour AP, Nutzinger B, Achilleos A, Edwards PA, Lynch AG, Tavaré S, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium.

Nat Genet. 2017 Jan 31;49(2):317. doi: 10.1038/ng0217-317a. No abstract available.

PMID:
28138154
6.

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Secrier M, Li X, de Silva N, Eldridge MD, Contino G, Bornschein J, MacRae S, Grehan N, O'Donovan M, Miremadi A, Yang TP, Bower L, Chettouh H, Crawte J, Galeano-Dalmau N, Grabowska A, Saunders J, Underwood T, Waddell N, Barbour AP, Nutzinger B, Achilleos A, Edwards PA, Lynch AG, Tavaré S, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium.

Nat Genet. 2016 Oct;48(10):1131-41. doi: 10.1038/ng.3659. Epub 2016 Sep 5. Erratum in: Nat Genet. 2017 Jan 31;49(2):317.

7.

Whole-genome sequencing of nine esophageal adenocarcinoma cell lines.

Contino G, Eldridge MD, Secrier M, Bower L, Fels Elliott R, Weaver J, Lynch AG, Edwards PA, Fitzgerald RC.

F1000Res. 2016 Jun 10;5:1336. doi: 10.12688/f1000research.7033.1. eCollection 2016.

8.

Combined MEK and PI3K inhibition in a mouse model of pancreatic cancer.

Alagesan B, Contino G, Guimaraes AR, Corcoran RB, Deshpande V, Wojtkiewicz GR, Hezel AF, Wong KK, Loda M, Weissleder R, Benes CH, Engelman J, Bardeesy N.

Clin Cancer Res. 2015 Jan 15;21(2):396-404. doi: 10.1158/1078-0432.CCR-14-1591. Epub 2014 Oct 27.

9.

KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.

Tzatsos A, Paskaleva P, Ferrari F, Deshpande V, Stoykova S, Contino G, Wong KK, Lan F, Trojer P, Park PJ, Bardeesy N.

J Clin Invest. 2013 Feb;123(2):727-39. doi: 10.1172/JCI64535. Epub 2013 Jan 16.

10.

Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitations.

Bertani E, Testori A, Chiappa A, Misitano P, Biffi R, Viale G, Mazzarol G, De Pas T, Botteri E, Contino G, Verrecchia F, Bazolli B, Andreoni B.

World J Surg Oncol. 2012 Sep 10;10:184.

11.

Two-year follow-up of wound complications associated with laparoendoscopic single-site adjustable gastric banding.

Ayloo SM, Masrur MA, Contino G, El Zaeedi M, Giulianotti PC.

Surg Obes Relat Dis. 2013 Sep-Oct;9(5):696-700. doi: 10.1016/j.soard.2012.07.005. Epub 2012 Jul 25.

PMID:
22951077
12.

TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression.

Hezel AF, Deshpande V, Zimmerman SM, Contino G, Alagesan B, O'Dell MR, Rivera LB, Harper J, Lonning S, Brekken RA, Bardeesy N.

Cancer Res. 2012 Sep 15;72(18):4840-5. doi: 10.1158/0008-5472.CAN-12-0634. Epub 2012 Jul 11.

13.

RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis.

Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S, Ciciliano JC, Smas ME, Winokur D, Gilman AJ, Ulman MJ, Xega K, Contino G, Alagesan B, Brannigan BW, Milos PM, Ryan DP, Sequist LV, Bardeesy N, Ramaswamy S, Toner M, Maheswaran S, Haber DA.

Nature. 2012 Jul 26;487(7408):510-3. doi: 10.1038/nature11217. Erratum in: Nature. 2012 Oct 25;490(7421):570.

14.

Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.

Tzatsos A, Paskaleva P, Lymperi S, Contino G, Stoykova S, Chen Z, Wong KK, Bardeesy N.

J Biol Chem. 2011 Sep 23;286(38):33061-9. doi: 10.1074/jbc.M111.257667. Epub 2011 Jul 11.

15.

STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis.

Corcoran RB, Contino G, Deshpande V, Tzatsos A, Conrad C, Benes CH, Levy DE, Settleman J, Engelman JA, Bardeesy N.

Cancer Res. 2011 Jul 15;71(14):5020-9. doi: 10.1158/0008-5472.CAN-11-0908. Epub 2011 May 17.

16.

Pancreatic cancers require autophagy for tumor growth.

Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, Dell'antonio G, Mautner J, Tonon G, Haigis M, Shirihai OS, Doglioni C, Bardeesy N, Kimmelman AC.

Genes Dev. 2011 Apr 1;25(7):717-29. doi: 10.1101/gad.2016111. Epub 2011 Mar 15.

17.

Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers.

Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, Contino G, Deshpande V, Iafrate AJ, Letovsky S, Rivera MN, Bardeesy N, Maheswaran S, Haber DA.

Science. 2011 Feb 4;331(6017):593-6. doi: 10.1126/science.1200801. Epub 2011 Jan 13.

18.

Aggressive treatment approach for cloacogenic carcinoma of the anorectum: report from a single cancer center.

Bertani E, Chiappa A, Mazzarol G, Contino G, Lazzari R, Zampino MG, Viale G, Andreoni B.

Dig Surg. 2010;27(4):297-301. doi: 10.1159/000288644. Epub 2010 Jul 31.

PMID:
20689291
19.

Molecular imaging agents: impact on diagnosis and therapeutics in oncology.

Seaman ME, Contino G, Bardeesy N, Kelly KA.

Expert Rev Mol Med. 2010 Jul 15;12:e20. doi: 10.1017/S1462399410001511. Review.

20.

Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases.

Chiappa A, Bertani E, Makuuchi M, Zbar AP, Contino G, Viale G, Pruneri G, Bellomi M, Della Vigna P, Zampino MG, Fazio N, Travaini ML, Trifirò G, Corbellini C, Andreoni B.

Hepatogastroenterology. 2009 May-Jun;56(91-92):829-34.

PMID:
19621711
21.

Analysis of Single Nucleotide Polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients.

Rinaldi F, Botta A, Vallo L, Contino G, Morgante A, Iraci R, Catalli C, Silvestri G, Ventriglia VM, Politano L, Novelli G.

Acta Myol. 2008 Dec;27:82-9.

22.

Pathological classification of DCIS and planning of therapeutic management.

Buonomo O, Orsaria P, Contino G, Varvaras D, Gioia A, Bonanno E, Pistolese C, Cossu E, Perretta T, Schillaci O, Del Monte G, Roselli M, Mineo TC, Petrella G.

Anticancer Res. 2009 May;29(5):1499-506.

23.

The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy.

Chiappa A, Makuuchi M, Lygidakis NJ, Zbar AP, Chong G, Bertani E, Sitzler PJ, Biffi R, Pace U, Bianchi PP, Contino G, Misitano P, Orsi F, Travaini L, Trifirò G, Zampino MG, Fazio N, Goldhirsch A, Andreoni B.

Crit Rev Oncol Hematol. 2009 Oct;72(1):65-75. doi: 10.1016/j.critrevonc.2008.11.003. Epub 2009 Jan 14. Review.

PMID:
19147371
24.

Metachronous Colon Metastases from Gastric Adenocarcinoma: A Case Report.

Pace U, Contino G, Chiappa A, Bertani E, Bianchi PP, Fazio N, Renne G, Di Meglio G, Andreoni B.

Case Rep Oncol. 2009 May 26;2(2):92-96.

25.

Hereditary spastic paraplegia: clinical genomics and pharmacogenetic perspectives.

Contino G, Novelli G.

Expert Opin Pharmacother. 2006 Oct;7(14):1849-56. Review.

PMID:
17020412
26.

Expression analysis of the gene encoding for the U-box-type ubiquitin ligase UBE4A in human tissues.

Contino G, Amati F, Pucci S, Pontieri E, Pichiorri F, Novelli A, Botta A, Mango R, Nardone AM, Sangiuolo FC, Citro G, Spagnoli LG, Novelli G.

Gene. 2004 Mar 17;328:69-74.

PMID:
15019985
27.

Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction.

Mango R, Clementi F, Borgiani P, Forleo GB, Federici M, Contino G, Giardina E, Garza L, Fahdi IE, Lauro R, Mehta JL, Novelli G, Romeo F.

J Med Genet. 2003 Dec;40(12):933-6. No abstract available.

28.

Role of genetics in prevention of coronary atherosclerosis.

Novelli G, Borgiani P, Giardina E, Mango R, Contino G, Romeo F, Mehta JL.

Curr Opin Cardiol. 2003 Sep;18(5):368-71. Review.

PMID:
12960469
29.

PSA and second-line therapy of hormone refractory prostate carcinoma.

Serretta V, Rizzo I, Contino G, Pavone C, Pomara G, Melloni D, Pavone-Macaluso M.

Urol Int. 2001;66(3):131-4.

PMID:
11316973
30.

Score on a four-antigen recombinant immunoblot assay (RIBA-2) and hepatitis C virus RNA detection in RIBA-2-indeterminate blood donors.

Prati D, Capelli C, Contino G, Mozzi F, Zanella A.

Transfusion. 1994 May;34(5):454-5. No abstract available.

PMID:
8191575
31.

Antibody to hepatitis C virus in 1,305 Italian multiply transfused thalassaemics: a comparison of first and second generation tests. Cooleycare Group.

Rebulla P, Mozzi F, Contino G, Locatelli E, Sirchia G.

Transfus Med. 1992 Mar;2(1):69-70. No abstract available.

PMID:
1284983
32.

[Synchronous or metachronous urotheliomas of the bladder and urinary ducts. Clinical and prognostic considerations].

Pavone-Macaluso M, Contino G, Iacolino R, Ingargiola GB.

Arch Esp Urol. 1988 Jun;41(5):331-3. Spanish. No abstract available.

PMID:
3190270

Supplemental Content

Loading ...
Support Center